Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$19.58
+0.6%
$19.24
$17.24
$26.56
$898.80M0.97273,299 shs138,451 shs
Enovis Co. stock logo
ENOV
Enovis
$51.09
+0.1%
$58.38
$43.04
$66.14
$2.80B1.99490,094 shs564,981 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$55.96
-1.5%
$50.50
$16.96
$73.00
$1.54B1.23407,128 shs205,132 shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$21.37
+3.6%
$20.90
$18.61
$30.52
$1.60B1.65663,823 shs1.05 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.46%-1.17%-2.36%+2.42%-16.47%
Enovis Co. stock logo
ENOV
Enovis
+0.97%-2.09%-18.23%-15.38%-8.86%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
+10.89%+14.81%+2.62%+48.93%-20.48%
Veracyte, Inc. stock logo
VCYT
Veracyte
+2.53%+2.18%-3.73%-19.32%-12.77%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.8813 of 5 stars
3.24.00.00.02.33.32.5
Enovis Co. stock logo
ENOV
Enovis
3.0388 of 5 stars
3.51.00.00.02.51.72.5
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.3004 of 5 stars
1.50.00.00.01.92.50.6
Veracyte, Inc. stock logo
VCYT
Veracyte
3.5589 of 5 stars
3.31.00.04.42.60.80.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.33
Hold$31.0058.32% Upside
Enovis Co. stock logo
ENOV
Enovis
3.00
Buy$75.4347.64% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
3.00
Buy$55.00-1.72% Downside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.60
Moderate Buy$27.5028.69% Upside

Current Analyst Ratings

Latest ESTA, AVNS, ENOV, and VCYT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2024
Veracyte, Inc. stock logo
VCYT
Veracyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
5/7/2024
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
5/3/2024
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$82.00
4/15/2024
Veracyte, Inc. stock logo
VCYT
Veracyte
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$32.00 ➝ $28.00
4/10/2024
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$82.00
4/3/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$49.00 ➝ $60.00
4/1/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $65.00
2/29/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$46.00 ➝ $53.00
2/26/2024
Veracyte, Inc. stock logo
VCYT
Veracyte
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$22.00 ➝ $21.00
2/23/2024
Enovis Co. stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$73.00 ➝ $79.00
2/23/2024
Enovis Co. stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$73.00 ➝ $75.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$680.10M1.32$2.01 per share9.73$26.63 per share0.74
Enovis Co. stock logo
ENOV
Enovis
$1.71B1.64$6.37 per share8.02$62.66 per share0.82
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$165.15M9.30N/AN/A$0.71 per share78.82
Veracyte, Inc. stock logo
VCYT
Veracyte
$361.05M4.52$0.09 per share225.40$14.30 per share1.49

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$61.80M-$1.33N/A10.76N/A-9.15%4.10%2.99%8/14/2024 (Estimated)
Enovis Co. stock logo
ENOV
Enovis
-$33.26M-$1.50N/A16.70N/A-4.51%3.98%2.88%8/1/2024 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$78.50M-$3.04N/AN/AN/A-47.53%-357.81%-30.37%8/13/2024 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
-$74.40M-$1.03N/A2,137.00N/A-20.61%-2.02%-1.89%8/13/2024 (Estimated)

Latest ESTA, AVNS, ENOV, and VCYT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024Q1 2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.65-$0.58+$0.07-$0.58$35.61 million$37.17 million    
5/7/2024Q1 2024
Veracyte, Inc. stock logo
VCYT
Veracyte
-$0.19-$0.02+$0.17-$0.02$93.35 million$96.84 million    
5/2/2024Q1 2024
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.21$0.19-$0.02$0.40$162.90 million$166.10 million    
5/2/2024Q1 2024
Enovis Co. stock logo
ENOV
Enovis
$0.50$0.50N/A$2.32$505.62 million$516.00 million    
2/28/2024Q4 2023
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.95-$0.79+$0.16-$0.79$31.44 million$31.60 million      
2/22/202412/31/2023
Enovis Co. stock logo
ENOV
Enovis
$0.76$0.79+$0.03$1.53$444.34 million$455.00 million      
2/22/2024Q4 2023
Veracyte, Inc. stock logo
VCYT
Veracyte
-$0.07-$0.04+$0.03$0.31$95.49 million$98.20 million
2/20/202412/31/2023
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.37$0.36-$0.01$0.49$170.43 million$173.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Enovis Co. stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.14
2.28
1.47
Enovis Co. stock logo
ENOV
Enovis
0.40
2.10
1.03
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
10.26
3.06
1.67
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
4.66
4.40

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Enovis Co. stock logo
ENOV
Enovis
98.45%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.90%
Enovis Co. stock logo
ENOV
Enovis
2.40%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.44%
Veracyte, Inc. stock logo
VCYT
Veracyte
2.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3,77145.90 million44.10 millionOptionable
Enovis Co. stock logo
ENOV
Enovis
6,55054.85 million53.54 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
90827.46 million24.32 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
81576.45 million74.46 millionOptionable

ESTA, AVNS, ENOV, and VCYT Headlines

SourceHeadline
Veracyte’s Robust Performance and Growth Potential Reinforce Buy RatingVeracyte’s Robust Performance and Growth Potential Reinforce Buy Rating
markets.businessinsider.com - May 10 at 10:35 AM
Veracyte’s Strong Q1 Performance and Upbeat Outlook Justify Buy RatingVeracyte’s Strong Q1 Performance and Upbeat Outlook Justify Buy Rating
markets.businessinsider.com - May 10 at 10:35 AM
Veracyte (NASDAQ:VCYT) Given New $27.00 Price Target at Needham & Company LLCVeracyte (NASDAQ:VCYT) Given New $27.00 Price Target at Needham & Company LLC
americanbankingnews.com - May 10 at 1:48 AM
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
finance.yahoo.com - May 9 at 9:14 AM
Maintaining Buy on Veracyte: Strong Q1 Performance and Progress Toward ProfitabilityMaintaining Buy on Veracyte: Strong Q1 Performance and Progress Toward Profitability
markets.businessinsider.com - May 8 at 6:12 PM
Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call TranscriptVeracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 8 at 6:12 PM
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises 24 Sales ViewVeracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
zacks.com - May 8 at 9:56 AM
Needham & Company LLC Cuts Veracyte (NASDAQ:VCYT) Price Target to $27.00Needham & Company LLC Cuts Veracyte (NASDAQ:VCYT) Price Target to $27.00
marketbeat.com - May 8 at 9:35 AM
Veracyte (NASDAQ:VCYT) Posts  Earnings ResultsVeracyte (NASDAQ:VCYT) Posts Earnings Results
marketbeat.com - May 8 at 8:41 AM
Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...
finance.yahoo.com - May 8 at 3:54 AM
Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test PerformanceVeracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
finance.yahoo.com - May 7 at 10:54 PM
Veracyte, Inc. 2024 Q1 - Results - Earnings Call PresentationVeracyte, Inc. 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 7 at 5:15 PM
Veracyte Announces First Quarter 2024 Financial ResultsVeracyte Announces First Quarter 2024 Financial Results
businesswire.com - May 7 at 4:05 PM
Heres what to expect from Veracytes earningsHere's what to expect from Veracyte's earnings
markets.businessinsider.com - May 7 at 4:42 AM
14 Studies Presented at AUA 2024 Show Decipher Tests Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding14 Studies Presented at AUA 2024 Show Decipher Tests' Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
businesswire.com - May 6 at 4:05 PM
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Fisher Asset Management LLCVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Fisher Asset Management LLC
marketbeat.com - May 5 at 8:13 AM
Veracyte (VCYT) Scheduled to Post Quarterly Earnings on TuesdayVeracyte (VCYT) Scheduled to Post Quarterly Earnings on Tuesday
americanbankingnews.com - May 5 at 4:10 AM
Vestmark Advisory Solutions Inc. Acquires New Holdings in Veracyte, Inc. (NASDAQ:VCYT)Vestmark Advisory Solutions Inc. Acquires New Holdings in Veracyte, Inc. (NASDAQ:VCYT)
marketbeat.com - May 4 at 2:39 PM
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by New York State Common Retirement FundVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by New York State Common Retirement Fund
marketbeat.com - April 27 at 6:34 AM
Diagnostics pioneer Bonnie Anderson launches PinkDx to focus on womens healthDiagnostics pioneer Bonnie Anderson launches PinkDx to focus on women's health
bizjournals.com - April 26 at 9:51 AM
Semanteon Capital Management LP Makes New $1.24 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)Semanteon Capital Management LP Makes New $1.24 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)
marketbeat.com - April 25 at 10:36 PM
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
businesswire.com - April 22 at 5:00 PM
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active SurveillanceNew Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
finance.yahoo.com - April 22 at 12:52 PM
New Study Shows Veracytes Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active SurveillanceNew Study Shows Veracyte's Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
businesswire.com - April 22 at 8:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avanos Medical logo

Avanos Medical

NYSE:AVNS
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Enovis logo

Enovis

NYSE:ENOV
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Establishment Labs logo

Establishment Labs

NASDAQ:ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Veracyte logo

Veracyte

NASDAQ:VCYT
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.